Skip to main content
Anteris Technologies Global Corp. logo

Anteris Technologies Global Corp. — Investor Relations & Filings

Ticker · AVR ISIN · US03675P1021 ASX Manufacturing
Open in API
Filings indexed 1,664 across all filing types
Latest filing 2018-12-18 Director's Dealing
Country US United States of America
Listing ASX AVR

About Anteris Technologies Global Corp.

https://anteristech.com/

Anteris Technologies is a structural heart company focused on the development and commercialization of medical devices for heart valve disease. Its lead product is the DurAVR® Transcatheter Heart Valve (THV), a biomimetic valve designed for patients with severe aortic stenosis. The DurAVR® THV is engineered to mimic the performance of a healthy human aortic valve, aiming to restore normal, laminar blood flow. Clinical studies have shown the device delivers a favorable hemodynamic profile, characterized by low pressure gradients and a significant reduction in prosthesis-patient mismatch (PPM), even in patients with challenging anatomies. The company is advancing its technology through pivotal clinical trials to establish a new standard in transcatheter aortic valve replacement (TAVR) and improve long-term patient outcomes.

Recent filings

Filing Released Lang Actions
Initial Director's Interest Notice 2 pages 159.8KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the director's relevant interests in securities, including direct and indirect holdings, and notes the date of appointment. There is no financial data, earnings information, or report content. This is a notification of personal share transactions or holdings by a company director, which fits the definition of Director's Dealing filings.
2018-12-18 English
Appendix 3B 14 pages 390.7KB
Capital/Financing Update Classification · 100% confidence The document is titled 'Appendix 3B New issue announcement' and contains detailed information about the issuance of new shares and options by Admedus Limited. It includes specifics such as the number and class of securities issued, issue price, purpose of the issue, security holder approvals, underwriting fees, and quotation application for the securities on the ASX. The document references ASX rules and the Corporations Act, indicating it is a formal announcement related to capital raising and securities issuance. There are no financial statements or management discussion of financial results, so it is not an Annual Report or Interim Report. It is not a call transcript, audit report, or governance document. The content clearly fits the category of a Capital/Financing Update, as it details new share issues, options, underwriting, and related capital structure changes.
2018-12-17 English
NOTICE OF DELAY OF ALLOTMENT IN SHARES 2 pages 78.8KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement titled 'NOTICE OF DELAY OF ALLOTMENT IN SHARES' from Admedus Limited. It discusses a delay in the allotment of new shares and options related to a previously announced entitlement offer. The content focuses on the timing of share allotment and trading commencement, with no financial statements or detailed financial analysis included. The document length is short (2458 characters) and it is clearly an announcement about a capital raising event, specifically the delay in allotment of shares. This fits the category of Capital/Financing Update (CAP) rather than a full financial report or other categories.
2018-12-16 English
Entitlement Offer Shortfall Notice 3 pages 84.2KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 14 December 2018 from Admedus Limited regarding the results of an entitlement offer, including details on the number of new shares and options issued, shortfall securities, and the expected allotment and trading dates. It is a communication about a capital raising event and the placement of shares and options, which fits the category of a Capital/Financing Update. The document is relatively short (3956 characters) and does not contain full financial statements or detailed financial analysis, so it is not an Annual Report or Interim Report. It is not a report publication announcement since it contains substantive information about the capital raising outcome. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2018-12-13 English
Director Appointments 2 pages 83.6KB
Board/Management Information Classification · 100% confidence The document is an ASX announcement dated 12 December 2018 regarding the appointment of two new non-executive directors to the Board of Directors of Admedus Ltd. It details the backgrounds of the appointees and their expected contributions to the company. There is no financial data, no mention of a report or financial results, and the content focuses solely on changes in the company's board composition. This fits the definition of Board/Management Information (MANG). The document length is 4441 characters, which is consistent with a typical announcement rather than a full report.
2018-12-11 English
Chief Medical Officer Appointment 2 pages 81.9KB
Board/Management Information Classification · 100% confidence The document is an announcement from Admedus Limited about the appointment of a new Chief Medical Officer, Dr. Kiran Bhirangi. It details his responsibilities, background, and the strategic importance of his role. There is no financial data, no mention of a report or filing, and no regulatory or legal content. The document is clearly about a change in senior management. Therefore, it fits the category of Board/Management Information (MANG). The document length is 3632 characters, which is consistent with a typical management announcement rather than a full report or regulatory filing.
2018-12-03 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.